Precision Medicine

Category

CodeBreak 100 Study: Sotorasib Zaps Lung & Colon Cancer Tumors in Majority of Participants

KRAS is a cancer gene has been studied for about 40 years, reports Memorial Sloan Kettering Cancer Center (MSKCC). It is known to be associated with a number of cancers such as about 25% of lung cancers and between 33% and 50% of colon and rectal cancers. Until...

University of Chicago Teams with Leukemia & Lymphoma Society to Drive Precision Cancer Care for Children

The age of precision medicine in cancer care for adults is rapidly approaching as it’s not uncommon now to select a treatment that’s actually tailored to each person’s unique tumor characteristics (biomarkers) as well as genetic changes in their specific cancer. For...

OneOncology and Foundation Medicine Unveil First-of-its-Kind Partnership to Advance Personalized Medicine at Community Oncology Practices

Foundation Medicine, Inc. and OneOncology announced today, August 17th, 2020, a new joint initiative that is intended to better enable OneOncology partner practice physicians to unlock the potential of precision oncology through comprehensive genomic profiling (CGP)...

America’s 7th Largest City Moving and Shaking in the World of Precision Therapeutics as Four Big Players Create Research Collaborative

Recently the San Antonio Partnership for Precision Therapeutics (SA PPT) was established by UT Health San Antonio, Texas Biomedical Research Institute (Texas Biomed), the University of Texas at San Antonio (UTSA) and Southwest Research Institute (SwRI®)....

Personalized Gene-Edited Immune Cell Therapy for Patients with Solid Cancers: Verifying Patient-Specific Cancer Mutation Targets

Background: Precision Cancer Therapies PACT Pharma, a leader in the fields of cancer immunology and cell therapy in collaboration with a UCLA team, presented new data demonstrating for the first time the ability to identify mutation targets unique to each patient’s...

Pin It on Pinterest